Differential target multiplexed spinal cord stimulation using a paddle-type lead placed at the appropriate site for neuropathic pain after spinal cord injury in patients with past spinal surgical histories: study protocol for an exploratory clinical trial
- PMID: 37308986
- PMCID: PMC10262581
- DOI: 10.1186/s13063-023-07433-7
Differential target multiplexed spinal cord stimulation using a paddle-type lead placed at the appropriate site for neuropathic pain after spinal cord injury in patients with past spinal surgical histories: study protocol for an exploratory clinical trial
Abstract
Background: Neuropathic pain after spinal cord injury (SCI), both traumatic and non-traumatic, is refractory to various treatments. Spinal cord stimulation (SCS) is one of the neuromodulation therapies for neuropathic pain, although SCS has insufficient efficacy for neuropathic pain after SCI. The reasons are presumed to be inappropriate locations of SCS leads and conventional tonic stimulation itself does not have a sufficient analgesic effect for the pain. In patients with past spinal surgical histories, the cylinder-type leads are likely to be placed on the caudal side of the SCI because of surgical adhesions. Differential target multiplexed (DTM) stimulation is one of the latest new stimulation patterns that is superior to conventional stimulation.
Methods: A single-center, open-label, randomized, two-way crossover trial is planned to investigate the efficacy of SCS using DTM stimulation placing a paddle lead at the appropriate site for neuropathic pain after SCI in patients with spinal surgical histories. The paddle-type lead delivers energy more efficiently than a cylinder-type lead. This study consists of two steps: SCS trial (first step) and SCS system implantation (second step). The primary outcome is rates of achieving pain improvement with more than 33% reduction 3 months after SCS system implantation. The secondary outcomes are to be evaluated as follows: (1) effectiveness of DTM and tonic stimulations during the SCS trial; (2) changes of assessment items from 1 to 24 months; (3) relationships between the result of the SCS trial and the effects 3 months after SCS system implantation; (4) preoperative factors associated with a long-term effect, defined as continuing for more than 12 months; and (5) whether gait function improves from 1 to 24 months.
Discussion: A paddle-type lead placed on the rostral side of SCI and using DTM stimulation may provide significant pain relief for patients with intractable neuropathic pain after SCI in patients with past spinal surgical histories.
Trial registration: Japan Registry of Clinical Trials (jRCT) jRCT 1042220093. Registered on 21 November 2022, and last modified on 6 January 2023. jRCT is approved as a member of the Primary Registry Network of WHO ICTRP.
Keywords: Differential target multiplexed; Neuropathic pain; Paddle lead; Spinal cord injury; Spinal cord stimulation.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Efficacy of the latest new stimulation patterns of spinal cord stimulation for intractable neuropathic pain compared to conventional stimulation: study protocol for a clinical trial.Trials. 2023 Sep 23;24(1):604. doi: 10.1186/s13063-023-07637-x. Trials. 2023. PMID: 37742013 Free PMC article.
-
Twelve-month results from a randomized controlled trial comparing differential target multiplexed spinal cord stimulation and conventional spinal cord stimulation in subjects with chronic refractory axial low back pain not eligible for spine surgery.N Am Spine Soc J. 2024 Jul 17;19:100528. doi: 10.1016/j.xnsj.2024.100528. eCollection 2024 Sep. N Am Spine Soc J. 2024. PMID: 39229594 Free PMC article.
-
Spinal Cord Stimulation for Neuropathic Pain following a Spinal Cord Lesion with Past Spinal Surgical Histories Using a Paddle Lead Placed on the Rostral Side of the Lesion: Report of Three Cases.NMC Case Rep J. 2022 Oct 13;9:349-355. doi: 10.2176/jns-nmc.2022-0218. eCollection 2022. NMC Case Rep J. 2022. PMID: 36381134 Free PMC article.
-
Current Evidence Lacking to Guide Clinical Practice for Spinal Cord Stimulation in the Treatment of Neuropathic Pain in Spinal Cord Injury: A Review of the Literature and a Proposal for Future Study.Pain Pract. 2020 Mar;20(3):325-335. doi: 10.1111/papr.12855. Epub 2020 Feb 10. Pain Pract. 2020. PMID: 31691496
-
Cervical Spinal Cord Stimulation for Trigeminal Neuralgia: a Narrative Review.Curr Pain Headache Rep. 2022 Aug;26(8):639-645. doi: 10.1007/s11916-022-01066-2. Epub 2022 Jun 18. Curr Pain Headache Rep. 2022. PMID: 35716273 Review.
Cited by
-
Efficacy of the latest new stimulation patterns of spinal cord stimulation for intractable neuropathic pain compared to conventional stimulation: study protocol for a clinical trial.Trials. 2023 Sep 23;24(1):604. doi: 10.1186/s13063-023-07637-x. Trials. 2023. PMID: 37742013 Free PMC article.
-
Differential target multiplexed spinal cord stimulation in patients with Persistent Spinal Pain Syndrome Type II: a study protocol for a 12-month multicentre cohort study (DETECT).BMJ Open. 2024 Nov 9;14(11):e083610. doi: 10.1136/bmjopen-2023-083610. BMJ Open. 2024. PMID: 39521475 Free PMC article.
-
Visualizing the modulation of neurokinin 1 receptor-positive neurons in the superficial dorsal horn by spinal cord stimulation in vivo.Pain. 2025 Feb 1;166(2):428-437. doi: 10.1097/j.pain.0000000000003361. Epub 2024 Aug 13. Pain. 2025. PMID: 39140483 Free PMC article.
-
Unintentionally intentional: unintended effects of spinal stimulation as a platform for multi-modal neurorehabilitation after spinal cord injury.Bioelectron Med. 2024 May 15;10(1):12. doi: 10.1186/s42234-024-00144-7. Bioelectron Med. 2024. PMID: 38745334 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous